|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 13822 |
FusionGeneSummary for FOXO3_FOXN3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FOXO3_FOXN3 | Fusion gene ID: 13822 | Hgene | Tgene | Gene symbol | FOXO3 | FOXN3 | Gene ID | 2309 | 1112 |
| Gene name | forkhead box O3 | forkhead box N3 | |
| Synonyms | AF6q21|FKHRL1|FKHRL1P2|FOXO2|FOXO3A | C14orf116|CHES1|PRO1635 | |
| Cytomap | 6q21 | 14q31.3-q32.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | forkhead box protein O3forkhead box O3Aforkhead homolog (rhabdomyosarcoma) like 1forkhead in rhabdomyosarcoma-like 1forkhead, Drosophila, homolog of, in rhabdomyosarcoma-like 1 | forkhead box protein N3checkpoint suppressor 1 | |
| Modification date | 20180527 | 20180519 | |
| UniProtAcc | O43524 | O00409 | |
| Ensembl transtripts involved in fusion gene | ENST00000343882, ENST00000406360, ENST00000540898, | ENST00000345097, ENST00000261302, ENST00000557258, ENST00000555353, ENST00000555658, | |
| Fusion gene scores | * DoF score | 4 X 2 X 3=24 | 8 X 7 X 6=336 |
| # samples | 4 | 8 | |
| ** MAII score | log2(4/24*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(8/336*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: FOXO3 [Title/Abstract] AND FOXN3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | FOXO3 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 20371612 |
| Hgene | FOXO3 | GO:0006417 | regulation of translation | 21329882 |
| Hgene | FOXO3 | GO:0043065 | positive regulation of apoptotic process | 20371612 |
| Hgene | FOXO3 | GO:0045648 | positive regulation of erythrocyte differentiation | 14734530 |
| Hgene | FOXO3 | GO:0045893 | positive regulation of transcription, DNA-templated | 10102273|15084260 |
| Hgene | FOXO3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 10102273|14734530 |
| Tgene | FOXN3 | GO:0045892 | negative regulation of transcription, DNA-templated | 16102918 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AK123151 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000343882 | ENST00000345097 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-3UTR | ENST00000343882 | ENST00000261302 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000343882 | ENST00000557258 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000343882 | ENST00000555353 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000343882 | ENST00000555658 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-3UTR | ENST00000406360 | ENST00000345097 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-3UTR | ENST00000406360 | ENST00000261302 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000406360 | ENST00000557258 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000406360 | ENST00000555353 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000406360 | ENST00000555658 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-3UTR | ENST00000540898 | ENST00000345097 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-3UTR | ENST00000540898 | ENST00000261302 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000540898 | ENST00000557258 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000540898 | ENST00000555353 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
| intron-intron | ENST00000540898 | ENST00000555658 | FOXO3 | chr6 | 108941819 | + | FOXN3 | chr14 | 89622792 | - |
Top |
FusionProtFeatures for FOXO3_FOXN3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FOXO3 | FOXN3 |
| Transcriptional activator which triggers apoptosis inthe absence of survival factors, including neuronal cell deathupon oxidative stress (PubMed:10102273, PubMed:16751106).Recognizes and binds to the DNA sequence 5'-[AG]TAAA[TC]A-3'(PubMed:21329882). Participates in post-transcriptional regulationof MYC: following phosphorylation by MAPKAPK5, promotes inductionof miR-34b and miR-34c expression, 2 post-transcriptionalregulators of MYC that bind to the 3'UTR of MYC transcript andprevent its translation (PubMed:21329882). In response tometabolic stress, translocates into the mitochondria where itpromotes mtDNA transcription (PubMed:23283301).{ECO:0000269|PubMed:10102273, ECO:0000269|PubMed:16751106,ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:23283301}. | Acts as a transcriptional repressor. May be involved inDNA damage-inducible cell cycle arrests (checkpoints).{ECO:0000269|PubMed:16102918}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FOXO3_FOXN3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FOXO3_FOXN3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FOXO3_FOXN3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for FOXO3_FOXN3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | FOXO3 | C0011853 | Diabetes Mellitus, Experimental | 2 | CTD_human |
| Hgene | FOXO3 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
| Hgene | FOXO3 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
| Hgene | FOXO3 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Hgene | FOXO3 | C0024117 | Chronic Obstructive Airway Disease | 1 | CTD_human |
| Hgene | FOXO3 | C0028754 | Obesity | 1 | CTD_human |
| Hgene | FOXO3 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|